| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Acadia Pharmaceuticals Inc. (ACAD) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. ACAD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 66.1K | $1.49M | -3,506 | |
| Dir | 35.0K | $790.5K | - | |
| Other | 29.1K | $657.2K | -1,332 | |
| 10% | 27.6K | $622.3K | - | |
| Dir | 25.4K | $572.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | Schneyer Mark C.59 | EVP, Chief Financial Officer | Sale+OE | 3,506 | $21.79 | $76,395.74 | -5.0% | - | - | |
| May 4, 2026 | Kihara James62 | Principal Accounting Officer | Sale+OE | 1,332 | $21.79 | $29,024.28 | -4.4% | - | - | |
| Mar 26, 2026 | Kihara James62 | Principal Accounting Officer | Sale+OE | 1,942 | $21.57 | $41,895.26 | -2.4% | - | - | |
| Mar 26, 2026 | Schneyer Mark C.59 | EVP, Chief Financial Officer | Sale+OE | 7,385 | $21.55 | $159,135.88 | -4.0% | - | - | |
| Mar 25, 2026 | Owen Adams Catherine | Chief Executive Officer | Sale+OE | 11,641 | $21.47 | $249,932.27 | -44.0% | - | - | |
| Mar 25, 2026 | Thompson Elizabeth H.Z. | EVP, Head Of Research &Dev | Sale+OE | 3,435 | $21.47 | $73,749.45 | -51.2% | - | - | |
| Mar 25, 2026 | Rhodes Jennifer J95 | EVP, Chief Legal Officer, Sec | Sale+OE | 3,844 | $21.47 | $82,530.68 | -25.4% | - | - | |
| Nov 18, 2025 | Schneyer Mark C.59 | EVP, Chief Financial Officer | Sale+OE | 10,262 | $23.69 | $243,113.96 | -16.1% | -3.6% | - | |
| Nov 18, 2025 | Kihara James62 | Principal Accounting Officer | Sale+OE | 4,084 | $23.69 | $96,753.64 | -14.0% | -3.6% | - | |
| Nov 10, 2025 | Daly James M | Director | Sell | 30,000 | $22.37 | $670,983.00 | -88.1% | +4.6% | - |